231. H. A. Santos*, “Empowering nanomedicines for drug- and gene-targeted delivery to the infarcted myocardium”, The 17th Edition of the European Symposium on Controlled Drug Delivery, April 10–12, 2024, Egmond Aan Zee, The Netherlands. (invited talk).
230. H. A. Santos*, “Micro/nano-based drug delivery platforms for biomedical applications”, Friedrich-Alexander-Universität, Faculty of Engineering, Department Materials Science and Engineering, April 4, 2024, Erlangen, Germanny (invited talk).
229. H. A. Santos*, “How To Publish Your Manuscript Successfully with Wiley (in Portuguese) - B-On”, Wiley Workshop for the Portuguese scientific community in Portugal, March 20 and April 2, 2024, online. (invited talk).
228. H. A. Santos*, “Novel nanotherapy target for tele-conditioning myocardial reperfusion injury: A nanosystem screening for targeted gene intervention”, Nature Conferences: Nanomaterials in Biomedical Applications, February 26-27, 2024, Manipal, India. (invited talk).
227. H. A. Santos*, “Mini-Course on Nanotechnology and Nanomedicines for Medical Applications: Empowering nanomedicines for drug- and gene delivery for cancer and myocardium infarction therapies”, University of Sao Paulo, February 17-23rd 2024, São Paulo, Brazil. (invited professorship lectures).
226. H. A. Santos*, “How to empower nanomedicines for drug- and gene delivery to macrophages and the injured heart tissue?”, XVth Spanish-Portuguese Conference on Controlled Drug Delivery, February 14-16th 2024, Lisbon, Portugal. (invited lecture).
225. H. A. Santos*, “Nano-biomaterials for biomedical applications: Boosting cancer antitumor immunity and mitochondria-targeting for reactive oxygen species generation”, 32th Annual Meeting of the Netherlands Society for Biomaterials and Tissue Engineering (NBTE), 30 November-1 December 2023, De Werelt, The Netherlands. (invited lecture).
224. H. A. Santos*, “Biomaterials for pharmaceutical and medical applications: from nanomedicines to microneedle platforms for precise delivery therapies”, Shanghai Jiao Tong University School of Medicine, 21 November 2023, Shanghai, China. (invited lecture).
223. H. A. Santos*, “Porous silicon-based nanoparticles for boosting cancer antitumor immunity and mitochondria-targeting for reactive oxygen species generation”, Semi-conducteurs et Oxydes Poreux (SCOPe), 9-10 November 2023, Louvain-la-Neuve, Belgium. (invited speaker).
222. H. A. Santos*, “Nanotechnology and healthcare: Revolutionizing the modern medicine with nanomedicines”, The HOVO Noord-Nederland University-courses for seniors, 2 November 2023, Groningen, The Netherlands. (invited lecture).
221. H. A. Santos*, “Nano-biomaterials for precise targeted delivery of biological drugs for biomedical applications”, International MicroNano Conference 2023, 30-31 October 2023, Utrecht, The Netherlands. (invited speaker).
220. H. A. Santos*, “State-of-the-art microfluidic methodologies for development of micro- and nanoparticles: application to drug delivery technologies”, AAPS 2023 PHARMSCI 360, 22-25 October 2023, Orlando, USA. (keynote speaker).
219. H. A. Santos*, “Rational design of nanosystems for potent gene silencing and targeting of myocardium infarction”, Israeli Controlled Release Society 2023 Conference, 5-7 September 2023, Galilion Hotel, Israel. (invited speaker).
218. H. A. Santos*, “Smart nanoparticle-based platforms for regulating tumor microenvironment, cancer immunotherapy and cardiac tissue repair”, Materials Today Conference 2023 - Elsevier B.V., 2-5 August 2023, Singapore, Singapore. (invited keynote talk).
217. H. A. Santos*, “Nanomedicines for precise targeted therapies: innovative drug delivery systems”, 1st Symposium & Summer School in Nanomedicine, Biomaterials and Bionanotechnology, University of Groningen – Universidad Nacional Autónoma de México, 19-22 June 2023, México City, México. (invited talk).
216. H. A. Santos*, “Design of nanoparticles for cancer immunotherapy and cardiac repair”, 1st Symposium & Summer School in Nanomedicine, Biomaterials and Bionanotechnology, University of Groningen – Universidad Nacional Autónoma de México, 19-22 June 2023, México City, México. (invited talk).
215. H. A. Santos*, “Why culture integration and diversity is important in a research team?”, UMCG Diversity & Inclusion Seminars, 8 June 2023, University Medical Center Groningen, The Netherlands. (invited talk).
214. H. A. Santos*, “Smart nanoparticle-based platforms for regulating tumor microenvironment and cancer immunotherapy”, The 2nd International Conference on Nanomedicine Meets the Tumor Microenvironment, 8-10 May 2023, University of Twente, Twente, The Netherlands. (invited talk).
213. H. A. Santos*, “Dissolving microneedles for drug delivery applications: Pain and heart diseases”, The International Conference on Emerging Technologies in Transdermal Drug Delivery, 17-19 April 2023, Naples, Italy. (invited talk).
212. H. A. Santos*, “Nanoformulation development of cancer therapy and cardiac repair”, 21st International Symposium, Controlled Release Society Indian Chapter, 24-25 February 2023, Mumbai, India. (invited talk).
211. H. A. Santos*, “Nanomedicines and biomaterials for cancer photo-chemo-immunotherapy applications”, Department of Medical Oncology, University Medical Center Groningen, 13 January 2023, The Netherlands. (invited talk).
210. H. A. Santos*, “Solving medical problems using 'smart' nanobiomaterials", Groningen Research Institute for Asthma and COPD (GRIAC) Retreat meeting, Groningen, 9 December, 2022, The Netherlands. (invited talk).
209. H. A. Santos*, “Design of nanoparticles for cancer immunotherapy and cardiac repair", 2022 Annual Meeting & International Conference of the KSPST: Comprehensive Approach For Post-Pandemic Drug Development Using Bio-Pharmaceutical Technology, Seoul, 1-2 December, 2022, South Korea. (invited keynote talk).
208. H. A. Santos*, “Nanoparticles for cancer immunotherapy and cardiac repair: From design towards clinical applications", Drug Delivery Australia 2022, University of South Australia, Adelaide, 24-25th November, 2022, Australia. (invited keynote talk).
207. H. A. Santos*, “Nanomedicines for targeted therapies: study cases for cancer and heart diseases", 9th International Forum of Laboratory Medicine, Jiangsu University, 20th November, 2022, China. (invited online talk).
206. H. A. Santos*, “Multifunctional nanomedicines for biomedical applications: From design and characterization to in vivo evaluation", Academic Symposium on Innovation and R&D of High-end Preparations, Chinese Pharmaceutical Association, 20th November, 2022, China. (invited online talk).
205. H. A. Santos*, “Cell-based nanomedicines for intracellular gene delivery", European Society of Gene and Cell Therapy (ESGCT), 11-14th October, 2022, Edinburgh, Scotland. (invited talk).
204. H. A. Santos*, “Microfluidic manufacturing of nano/micro-particle formulations for pharmaceutical and biomedical applications", 9th BBBB International Conference on Pharmaceutical Sciences, 15-17th September, 2022, Ljubljana, Slovenia. (invited plenary talk).
203. H. A. Santos*, “Multifunctional nanoparticles for combination therapy: modulating biomaterial–cell interactions for targeting and regenerative applications", CÚRAM, Centre for Research in Medical Devices – National University of Ireland, 18th July, 2022, Galway, Ireland. (invited talk).
202. H. A. Santos*, “Near-Infrared light-mediated multifunctional hydrogel for cancer photo-chemo-immunotherapy", 49th Controlled Release Society Annual Meeting & Exposition), 11-15th July, 2022, Montreal, Canada. (selected talk).
201. H. A. Santos*, “Biomimetic nanoparticles for biomedical applications", 49th Controlled Release Society Annual Meeting & Exposition), 11-15th July, 2022, Montreal, Canada. (invited talk).
200. H. A. Santos*, “Modulating biomaterial–cell interactions for targeted and regenerative therapies", The Spanish Royal Society of Chemistry (RSEQ) XXXVIII Biennial Meeting, Granada Convention Center, 27-30 June, 2022, Granada, Spain. (invited keynote talk).
199. H. A. Santos*, “Advances in controlled release technology: from design to applications”, "Controlled release technology: delivery systems for pharmaceuticals and other agents" Symposium, Baltic Biomaterials Centre of Excellence, 6 June 2022. (invited webinar).
198. H. A. Santos*, “Multifunctional nanoparticles for combination therapy: From design to photothermal, immunotherapy, and magnetic guided applications”, King’s College London Medicines Development Group, 18 May 2022. (invited webinar).
197. H. A. Santos*, “Porous biomaterials for solving medical problems: from design to biomedical applications”, NETPORE Cost Action Network – EU, 12 May 2022. (invited webinar).
196. H. A. Santos*, “Modulating biomaterial-cell interactions for targeting and regenerative therapeutic applications”, Advanced Materials and Devices for Nanomedicine (AMA4MED), Spain, 3-4 May 2022. (invited webinar).
195. H. A. Santos*, “Modulating nanoparticle–cell interactions for targeted, immunotherapy and regenerative medical applications”, Advanced Chemical Biology Online Forum-2022, China, 24 April 2022. (invited webinar).
194. H. A. Santos*, “Biomaterials for imaging and therapeutic applications: HTRIC and beyond”, Center for Medical Imaging North East Netherlands (CMI-NEN), University medical Center Groningen, The Netherlands, 22 April 2022. (invited lecture).
193. H. A. Santos*, “Materials for biomedical applications”, Materials2022, Polytechnic of Leiria, Marinha Grande, Portugal, 11–13 April 2022. (invited plenary talk).
192. H. A. Santos*, “Modulating nanocarrier–cell interactions for targeted and regenerative therapies”, European Research Institute for the Biology of Aging, University Medical Center Groningen, The Netherlands, 1st April 2022. (invited lecture).
191. H. A. Santos*, “Novel biohybrid nanomedicines for cancer therapy: from nanoformulation design to the in vivo validation”, 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 28-31 March 2022, Rotterdam, The Netherlands. (invited talk).
190. H. A. Santos*, “Modulating biomaterial-cell interactions for personalized targeting and regenerative therapies”, Applied Molecular Biosciences, UCIBIO, Universities of Porto/NOVA of Lisbon, 18th March 2022. (invited webinar).
189. H. A. Santos*, “Modulating biomaterial-cell interactions for personalized targeting and regenerative therapies”, Department of Biomedical Sciences of Cells & Systems, University of Groningen, 10th February 2022. (invited webinar).
188. H. A. Santos*, “Bioengineering of advanced biomaterials for biomedical applications: from design to animal studies”, Micro4Nano – MSCA-RISE Network, 9th February 2022. (invited webinar).
187. H. A. Santos*, “Bioengineering materials for solving medical problems: from design to in vivo applications”, Groningen Research Institute of Pharmacy, University of Groningen, 8 February 2022. (invited webinar).
186. H. A. Santos*, “Multistage signal-interactive nanoparticles improve tumor targeting through efficient nanoparticle-cell communications”, 2021 MRS Fall Meeting, 6-8 December 2021. (invited keynote talk).
185. H. A. Santos*, “Engineering biomaterials for solving medical problems”, HTRIC Research Meetup Event, Hanze Plaza, Groningen, The Netherlands, 1st October 2021. (invited keynote talk).
184. H. A. Santos*, “Nanotechnologies: a new generation of nanomedicines for biomedical applications”, PhD Webinar Series, Faculty of Pharmacy, University of Pavia, 30th September 2021. (invited webinar).
183. H. A. Santos*, “Nanomedicines and biomedical engineering”, W.J. Kolff Institute - University of Groningen, 3rd September 2021. (invited webinar).
182. H. A. Santos*, “Biohybrid nanomaterials for biomedical applications”, 48th Controlled Release Society Annual Meeting & Exposition, 25-29th July 2021, Online Virtual Meeting. (invited award webinar).
181. H. A. Santos*, “Nano Medicine for Precision Targeted Therapies”, 2nd Meeting of the Group of Portuguese Chemists Abroad of the SPQ, 10 June 2021. (invited plenary webinar).
180. H. A. Santos*, “Dressing Biohybrid Nanomaterials in Cell’s Clothing for Chemo-Immunotherapy Applications”, CRS Italy Local Chapter Webinar Series, 21 April 2021. (invited webinar).
179. H. A. Santos*, “Biohybrid Nanomaterials For Biomedical Applications”, 2nd Virtual European Polymer Conference, 19-21 April 2021. (invited webinar).
178. H. A. Santos*, “Innovative technologies in manifacturing of drug products”, 24 March 2021, Hovione Pharmaceutical Company Innovation Meeting. (invited webinar).
177. H. A. Santos*, “Cloaked Viral Nanovaccines and Exosome‐Based Nanoparticles for Chemo‐immunotherapeutic applications”, 5 March 2021, Research Institute for Medicines (iMed.ULisboa) , Faculty of Pharmacy, University of Lisbon, Portugal. (invited webinar).
176. H. A. Santos*, “The New Generation of Nanomedicines for Biomedical Applications: Dressing Nanoparticles in Cell’s Clothing”, 9 December 2020, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland. (invited webinar).
175. H. A. Santos*, “Fabrication of Porous Silicon Based Nanostructures For Drug Delivery Applications ", Baltic Biomaterials Centre of Excellence External Training e-event "Controlled release technology: delivery systems for pharmaceuticals and other agents”, 2–4 November 2020, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany. (invited e-lecture).
174. H. A. Santos*, “Tumor Exosome‐Based Nanoparticles and Artificially Cloaked Viral Nanovaccines for Chemo‐immunotherapy", CLINAM 2020, 12th European and Global Summit for Nanomedicine (Virtual Meeting), 26–28 October 2020, Basel, Switzerland. (invited e-talk).
173. H. A. Santos*, “Tumor Exosome-Based Nanoparticles and Artificially Cloaked Viral Nanovaccines for Chemo-immunotherapy Applications", Autumn Meeting for Young Chemists in Biomedical Sciences, 13–14 October 2020, Virtual Meeting, Italy. (invited plenary e-lecture).
172. H. A. Santos*, “A New Generation of Nanomedicines for Biomedical Applications", NanoPT, 23–24 September 2020, Virtual Meeting, Portugal. (invited keynote e-lecture).
171. H. A. Santos*, “A New Generation of Nanomedicines for Cancer Immunotherapy Applications", Materials Science and Engineering Congress (MSE) , 22–25 September 2020, Virtual Meeting, Germany. (invited keynote e-lecture).
170. H. A. Santos*, “Dressing Nanoparticles in Cell’s Clothing: The New Generation of Nanomedicines for Biomedical Applications", NanoInnovation 2020, 15-18 September 2020, Rome, Italy. (invited plenary e-lecture).
169. H. A. Santos*, “Nanomedicines and Microfluidics for Pharmaceutical Applications", Università degli Studi di Urbino "Carlo Bo", 2019-2020, PhD Program, Italy. (invited e-lectures).
168. H. A. Santos*, “Biofunctionalized Porous Silicon Nanomaterials For Biomedical Applications", 3 March 2020, Department of Chemistry and Biochemistry, College of Science and Engineering, Texas Christian University, Undergraduate level in Chemistry, USA. (invited e-lecture).
167. H. A. Santos*, “Development of Multifunctional Materials For Biomedical Applications", HYBER Center of Excellence Meetings, 3 March 2020, Department of Applied Physics/HYBER CoE, Aalto University School of Science, Espoo, Finland. (invited talk).
166. H. A. Santos*, “Tumor Exosome-Based Nanoparticles and Artificially Cloaked Viral Nanovaccines for Chemo-immunotherapy Applications", Department of Microbiology - Tumor and Cell Biology, 31 January 2020, Karolinska Institutet, Stockholm, Sweden. (invited talk).
165. H. A. Santos*, “Towards personalized nanomedicines for precision drug delivery", 10th Symposium on Pharmaceutical Profiling in Drug Discovery and Development, 30 January 2020, Uppsala University, Uppsala, Sweden. (keynote invited talk).
164. H. A. Santos*, “Nanobiostructured systems for biomedical applications: From design to cancer therapy", "25th ANNIVERSARY" XIIIth Spanish-Portuguese Conference on Controlled Drug Delivery, 22-24 January 2020, School of Medicine, Santiago de Compostela, Spain. (invited talk).
163. H. A. Santos*, “Nanomedicines dressed in cell’s clothing for cancer chemo-immunotherapy applications", 1st International Northern-Southern Europe Workshop in Nanomedicine, 15–17 January 2020, University of Chieti-Pescara “G. D’annunzio”, Chieti, Italy. (invited talk).
162. H. A. Santos*, “Nanomedicines dressed in cell’s clothing for cancer applications", Symposium "On the Way to Nanomedicine: Chemical concepts for conjugation of nanoparticles and biomolecules", 19 December 2019, University of Cologne, Cologne, Germany. (invited talk).
161. H. A. Santos*, “Nanomedicines for drug delivery applications", Seminar series - Fimea, 18 December 2019, Finnish Medicines Agency, Helsinki, Finland. (invited talk).
160. H. A. Santos*, “Dressing nanoparticles in cell’s clothing: The new generation of nanomedicines for biomedical applications", 18 November 2019, Imperial College London - Department of Materials, London, UK. (invited talk).
159. H. A. Santos*, “Nanomedicines for drug delivery applications", Advanced Spectroscopic Analytical Methods and New Technologies in Drug Delivery Workshop, 23-25 Ocotber 2019, University of Helsinki, Helsinki, Finland. (invited talk).
158. H. A. Santos*, “Nanomedicines and Microfluidics for Pharmaceutical Applications", University of Chieti-Pescara “G. D’annunzio”, Chieti, 2019-2020, Master's level in Pharmaceutical Sciences, Italy. (visiting professor lectures).
157. H. A. Santos*, “Nanobiostructures for Biomedical Applications", VII Scientific Workshop I.S.Mu.L.T. - Università di Teramo, 17 Ocotber 2019, Teramo, Italy. (plenary talk).
156. H. A. Santos*, “Biohybrid Nanotheranostic Materials for Cancer and Cardiovascular Applications", 8th BBBB Conference on Pharmaceutical Sciences, 14-16 Ocotber 2019, Çeşme, İzmir, Turkey. (invited talk).
155. H. A. Santos*, “Hybrid nanomedicines for biomedical applications”, The Institute of Nanoscience of Aragon, University of Zaragoza, 24 September 2019, Zaragoza, Spain. (invited talk).
154. H. A. Santos*, “Biomedical engineering and nanomedicines”, High School Biology and Geography Teachers Educational Day, 21 September 2019, Ressu High School, Helsinki, Finland. (invited talk).
153. H. A. Santos*, “Multifunctional nanomedicines for cancer and cardiovascular diseases”, 10th APS international PharmSci Conference, University of Greenwich, 11-13 September 2019, London, UK. (keynote invited talk).
152. H. A. Santos*, “Novel biohybrid nanosystems for efficient cancer chemo- and immuno-therapy applications”, EUROMAT2019, 1-5 September 2019, Stockholm, Sweden. (selected talk).
151. H. A. Santos*, “Nanomedicines for clinical translation: cancer and cardiovascular diseases”, Nordic POP - China Forum on Clinical and Translational Medicine, Pharmaceutical Sciences Laboratory, BioCity, Åbo Akademi University, 30 August 2019, Turku, Finland. (invited talk).
150. H. A. Santos*, “Multifunctional and biohybrid nanomaterials for cancer and cardiovascular applications" and "Microfluidic-based nanomedicines for biomedical applications”, The 15th Scientific Meeting of Chinese Society of Interventional Radiology (CSIR 2019), Shanghai International Convention Center, 11-14 July 2019, Shanghai, China. (invited talks).
149. H. A. Santos*, “Nanomedicines for biomedical applications: current status in drug targeting and delivery”, State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Biology, School of Life Sciences, Xiamen University, 10 July 2019, Xiamen, China. (invited talk).
148. H. A. Santos*, “Nanomedicines for drug delivery and targeting therapy” and “Microfluidics for pharmaceutical applications: from nano/micro systems fabrication to controlled drug delivery”, University of Helsinki, 29 June−5 July 2019, Helsinki, Finland. (invited full course 2× days).
147. H. A. Santos* , "Microfluidic fabrication of nanoparticles for biomedical applications", Sorbonne University - Campus Pierre & Marie Curie, 26-27 June 2019, Paris, France (plenary invited talk).
146. H. A. Santos* and A. Rahikkala, "How to approach the researchers", Helsinki Startup Day, 4 June 2019, Helsinki, Finland (invited talk).
145. H. A. Santos*, "Microfluidics technology to fabricate nanomedicines for biomedical applications", FIRST COST ACTION CA17140 Training School, University of Trieste, 8-11 April 2019, Trieste, Italy (invited talk).
144. H. A. Santos*, "Chit-chat about nanomedicines", PechaKucha event, Great Hall, University of Helsinki, 4 April 2019, Helsinki, Finland (invited talk).
143. H. A. Santos*, "Biohybrid nanovaccines for cancer immunotherapy applications", Workshop on NanoBioMedicine in Naples: the Next Future of Theranostics, National Research Council - Naples Research Area 1, 22 March 2019, Naples, Finland (keynote invited talk).
142. H. A. Santos*, "Microfluidics fabrication of nanomedicines", EUFEPS Annual Meeting 2019, 6-8 March 2019, Frankfurt, Germany (invited talk).
141. H. A. Santos*, "ERC: proof-of-concept discussion", Solving global challenges with science, University of Helsinki, Tiedekulma, 20 February 2019, Helsinki, Finland (invited talk).
140. H. A. Santos*, "How nanomedicines will help our doctors in the future", 16th Science Day of the Kontinkangas Campus, 18 February 2019, University of Oulu, Oulu, Finland (invited talk).
139. H. A. Santos*, "Nanomedicines: the next generation of smart precision drugs", Helsinki Health Week, Tätä Et Oppinut Koulussa, University of Helsinki, Tiedekulma, 24 January 2019, Helsinki, Finland (invited talk).
138. H. A. Santos*, "Hydrogel nanofibrous scaffolds for rapidly recruiting angiogenesis relative cells in diabetic wounds", 2nd Diabetic Wound Healing Workshop, 3-4 January 2019, Roskilde University, Roskilde, Denmark (invited talk).
137. H. A. Santos*, "Multifunctional nanomedicine for ischemic myocardial injury, Biohybrid nanovaccine for melanoma, and Microfluidics for drug delivery and biomedical applications", Course on Nanomedicine and Nanotechnology, 3-7 December 2018, University of Tromsø – The Arctic University of Norway, Norway (invited talk).
136. H. A. Santos*, "Nanomedicines for targeted drug delivery and precision medicine", Course on Biosensor Assemblies and their Applications, Health and Biosciences Doctoral Programme (HBS-DP), 3-4 November 2018, Oulu, Finland (invited talk).
135. H. A. Santos*, "Biohybrid nanovaccines for improved treatment of aggressive melanoma", Cancer Immunotherapy Workshop and Training, 20-23 November 2018, Riga Stradins University, Riga, Latvia (invited talk).
134. H. A. Santos*, "Homing-targeted nanomedicines for biomedical applications", The Royal Society of Chemistry Finnish section Annual Seminar 2018, 2 November 2018, Åbo Akademi University, Turku, Finland (invited talk).
133. H. A. Santos*, "Small size particles for a big medical revolution", FinPharmSci 2018, 31 October 2018, Helsinki, Finland (invited talk).
132. H. A. Santos*, "Engineered nanomedicines for enhanced tumor-penetration, prevent cancer recurrence, and tissue regeneration", College of Life Science and Technology, Huazhong University of Science and Technology, 20 October 2018, Wuhan, China (invited talk).
131. H. A. Santos*, "Engineered nanomedicines for enhanced tumor-penetration and tissue regeneration", Department of Chemistry and Materials Science, University of Nanjing Forestry University, 17 October 2018, Nanjing, China (invited talk).
130. H. A. Santos*, "Engineered materials to improve tumor-penetration, prevent cancer recurrence, promote vascularization and tissue regeneration", Seminar Cycle in Biophysical Sciences, Scuola Normale Superiore - Pisa, 17 September 2018, Pisa, Italy (invited talk).
129. H. A. Santos*, "Nanoparticles for imaging and therapy", Workshop "From Nanotoxicology to Nanomedicine", 7 September 2018, Tallinn, Estonia (invited talk).
128. H. A. Santos*, "Multifunctional nanomedicines for targeted drug delivery and imaging for ischemic myocardial injury", CLINAM 2018, 2–5 September 2018, Basel, Switzerland (invited talk).
127. H. A. Santos*, "Advanced multifunctional nanomedicines for biomedical applications", Frontiers in Delivery of Therapeutics, 21-24 August 2018, Tartu, Estonia (invited talk).
126. H. A. Santos*, "Nanomedicines for personalized medicines", Università degli Studi “G. d´Annunzio” di Chieti – Pescara, 18-22 June 2018, Chieti, Italy (Erasmus staff mobility for teaching).
125. H. A. Santos*, "Popularising science", FinPharmaNet Symposium 2018, 14-15 June 2018, Hotel Korpilampi/Nuuksio, Finland (invited lecture).
124. H. A. Santos*, "Fabrication of multifunctional nanoparticles by microfluidics for drug delivery and biomedical applications", International Workshop in Microfluidics and Pharmaceutical Nanotechnology, 7-8 June 2018, Viikki campus - University of Helsinki, Helsinki, Finland (invited talk).
123. H. A. Santos*, "Fabrication of multifunctional nanoparticles by microfluidics for drug delivery and biomedical applications", Micronano System Workshop, 13-18 May 2018, Otaniemi campus - Aalto University, Espoo, Finland (invited talk).
122. H. A. Santos*, "Nanomedicine - the 'MacGyver' Swiss Army knife to regenerate a healthy heart", TEDxHelsinkiUniversity 2018, 11 May 2018, Helsinki, Finland (selected talk).
121. H. A. Santos*, "Nanomedicines and biomedical engineering", Scientific Teaser Talks, Faculty of Medicine – Biomedicum, 22 March 2018, Helsinki, Finland (invited lecture).
120. H. A. Santos*, "Biohybrid multistage nanovaccines based on acetalated dextran-coated pSi nanoparticles: development of an innovative formulation", Porous Semiconductors-Science and Technology 2018, 11-16 March 2018, La Grande Motte, France (selected lecture).
119. H. A. Santos*, "Multifunctional nanoparticles targeted to the endocardial layer of the injured heart", Faculty of Medicine – Biomedicum, 15 November 2017, Helsinki, Finland (invited lecture).
118. H. A. Santos*, "Multifunctional nanohybrid based on porous silicon nanoparticles, gold nanoparticles and acetalated dextran for liver regeneration and acute liver failure theranostics", Leibniz Institute for Photonic Technologies (IPHT), 12-14 November 2017, Jena, Germany (invited lecture).
117. H. A. Santos*, “Nanomedicines that will revolutionize the healthcare” (Virtual Talk), Kharkiv National Medical University, 8–10 November 2017, Ukraine (invited talk).
116. H. A. Santos*, "Multifunctional nanoparticles for drug delivery and pharmaceutical applications", Faculty of Pharmaceutical Science, Prince of Songkla University, 24 October 2017, Songkhla, Thailand (invited lecture).
115. H. A. Santos*, "Targeted nanomedicines for biomedical applications", Institute of Translational Medicine, Medical School, Zhejiang University, 22 October 2017, Hangzhou, China (invited lecture).
114. H. A. Santos*, "Targeted nanoparticles for drug delivery to cancer and cardiovascular diseases", School of Life Science and Technology, Huazhong University of Science and Technology, 20 October 2017, Wuhan, China (invited lecture).
113. H. A. Santos*, "Porous silicon based nanocomposites for biomedical applications: from cancer to cardiovascular diseases", 6th International Symposium on Surface and Interface of Biomaterials, 16–19 October 2017, Chengdu, China (invited plenary talk).
112. H. A. Santos*, "Multifunctional nanoparticles for biomedical applications", Department of Biomedical Engineering, Chongqing University, 15 October 2017, Chongqing, China (invited lecture).
111. H. A. Santos*, "Fighting diseases with invisible and tiny drug carriers (nano-medicines)", Faculty of Pharmacy, 14 September 2017, Helsinki, Finland (invited talk).
110. H. A. Santos*, "Targeted nanomedicines for cancer, diabetes and cardiovascular diseases: why the size matters?", YUCOMAT 2017, 4–8 September 2017, Herceg Novi, Montenegro (invited plenary talk).
109. H. A. Santos*, "Course - Microfluidics for pharmaceutical applications: From nano/micro systems fabrication to controlled drug delivery", KU Leuven, 11-13 July 2017, Leuven, Belgium (1 Day course, invited).
108. H. A. Santos*, "Lessons from nanomedicines: from the nanoworld to biomedical applications", Institute of Biotechnology, Vilnius University, 30 June 2017, Vilnius, Lithuania (invited talk).
107. H. A. Santos*, "Multifunctional nanomaterials for drug delivery and theranostic applications", 3rd International Conference Current Trends in Cancer Theranostics (CTCT-2017), 25-29 June 2017, Pakruojis Castle, Lithuania (invited keynote talk).
106. H. A. Santos*, "Small is more: nanomaterials for drug delivery and theranostic applications”, Centre of Excellence in Computational Nanoscience Seminar - Aalto University, 9 June 2017, Espoo, Finland (invited talk).
105. H. A. Santos*, "Homing-target nanoporous silicon nanoparticles for myocardium infarcted therapy", 2017 E-MRS Spring Meeting and Exhibit, 22-25 May 2017, Strasbourg, France (invited talk).
104. H. A. Santos*, "Targeting drug nanosystems for cancer, diabetes and cardiovascular diseases", II International Congress in Health Sciences Research: Towards Innovation and Entrepreneurship, 17-20 May 2017, Covilhã, Portugal (invited talk).
103. H. A. Santos*, "Preclinical development of nanomedicines for biomedical applications", Deptartment of Rheumatology and Inflammation Research, University of Göteborg, Göteborg, Sweden (invited talk).
102. H. A. Santos*, "Targeted nanomedicines for cancer, diabetes and cardiovascular diseases: from concept to application", Spring workshop, 10-12 May 2017, Tartu, Estonia (invited talk).
101. H. A. Santos*, "Targeted nanosystems for imaging and therapy: why the size matters?", Biomedicum Helsinki Seminar - University of Helsinki , 17 March 2017, Helsinki, Finland (invited talk).
100. H. A. Santos*, "Nanomedicines: Bridging Between Chemistry and Pharmaceutical Nanotechnology", Finnish Chemical Society Spring Meeting, 8 March 2017, Helsinki, Finland (invited talk).
99. H. A. Santos*, "Nanomedicines for Healthcare Applications", 3rd BiotechHealth Symposium - "Emerging technologies in Health Sciences", 21 June 2016, i3s – Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal (invited talk).
98. H. A. Santos*, "Preclinical development of porous silicon nanocomposites for translational biomedical research", Faculty of Pharmacy Research Seminar 2016, 31 May 2016, Koskenranta – Helsinki, Finland invited talk).
97. H. A. Santos*, "Bridging between engineering and medicine – Current applications of nanomedicines for cancer, diabetes and cardiovascular diseases", The 5th Portuguese Young Chemists Meeting (5th PYCheM) and 1st European Young Chemists Meeting (1st EYCheM), 27 April 2016, Centro Cultural Vila Flor – Guimarães, Portugal (plenary talk).
96. H. A. Santos*, "Innovative biomaterials for healthcare applications", Aveiro Institute of Materials, 26 April 2016, , University of Aveiro, Aveiro, Portugal (invited talk).
95. H. A. Santos*, "The invisible nano-world for treating diseases", Meilahti Campus Day – Biomedicum Helsinki, Faculty of Medicine, 22 March 2016, University of Helsinki, Helsinki, Finland (invited talk).
94. H. A. Santos*, "Porous Silicon Based Drug Delivery Systems", Introduction to Nanoscience course, Faculty of Pharmacy, 22 February 2016, University of Helsinki, Helsinki, Finland (invited talk).
93. H. A. Santos*, "Past, Present and Future of Nanomedicines", Department of Pharmacy, Faculty of Health and Medical Sciences, 18 March 2016, University of Copenhagen, Copenhagen, Denmark (invited talk).
92. H. A. Santos*, "Targeted Drug Delivery Using Nanocarriers", Orion Pharma, 12 February 2016, Espoo, Finland (invited talk).
91. H. A. Santos*, "Innovative Nanomedicines for Heart and Brain Diseases", Biomedicum Helsinki, Institute of Biomedicine - University of Helsinki, Heart Regeneration & Repair Investigators' Meeting, 16 December 2015, Helsinki, Finland (invited talk).
90. H. A. Santos*, "Innovative Micro and Nanocomposites For Biomedical Applications", I3s/INEB – University of Porto, 2 December 2015, Porto, Portugal (invited talk).
89. H. A. Santos*, "Targeted Nanomedicines for Cancer Therapy", The 11th Conference in Organic and Medicinal Chemistry by the Portuguese Chemical Society (SPQ), 1-3 December 2015, Porto, Portugal (invited talk).
88. H. A. Santos*, "Pre-Clinical Development of Micro and Nanocomposites for Translational Medicine", NanotechItaly 2015, 25-27 November 2015, Bologna, Italy (invited talk).
87. H. A. Santos*, "Preclinical Development of Nanomedicines - Bridging the Gap Between Engineering and Medicine", Department of Chemistry, University of Basel, 24 November 2015, Basel, Switzerland (invited lecture).
86. H. A. Santos*, "Innovative Drug Delivery Systems", 3i Regeneration Partnering Event, 28 October 2015, Helsinki, Finland (invited talk).
85. H. A. Santos*, "Micro- and Nanocomposites For Translational Medicine: Bridging the Gap Between Nanotechnology and Medicine", Department of Chemistry, University of Eastern Finland, 22 October 2015, Joensuu, Finland (invited lecture).
84. H. A. Santos*, "In Vivo Biocompatibility of Porous Silicon-Based Materials For Controlled Drug Delivery Applications", pSiMedica, Malvern Hills Science Park, 28 July 2015, Worcestershire, UK (invited lecture).
83. H. A. Santos*, "Hybrid Multicomposites For Biomedical Applications", School of Life Sciences, Fudan University, 27 June 2015, Shanghai, China (invited lecture).
82. H. A. Santos*, "Preclinical Development of Biomaterials For Translational Medicine: From Bench to Bedside", Jiangsu Province Hospital, 26 June 2015, Nanjing, China (invited lecture).
81. H. A. Santos*, "Porous Biomaterials and Microfluidics For Biomedical Applications", Orthopedic Institute, Soochow University, 25 June 2015, Suzhou, China (invited lecture).
80. H. A. Santos*, "Bioinspired nanomedicines towards personalized therapy", Bioinspired Engineering and Biomechanics Center and School of Life Science and Technology, Xi’an Jiaotong University, 24 June 2015, Xi'an, China (invited lecture).
79. H. A. Santos*, "Fabrication of nanomedicines for precisely controlled combination therapy", Stem cell and Regeneration Center, The Academy of Military Medical Sciences, 19 June 2015, Beijing, China (invited lecture).
78. H. A. Santos*, "Novel drug delivery technologies for biomedical applications", 12th Annual Controlled Release Conference, 20-21 April 2015, London, UK (invited lecture).
77. D. Liu, H. Zhang, B. Herranz-Blanco, M.-A. Shahbazi, C.-F. Wang, E. Mäkilä, V. Balasubramanian, S. Cito, Y. Zhang, T. M. Sikanen, D. A. Weitz, J. Salonen, J. Hirvonen, H. A. Santos*, "Smart and multitasking nanomedicines for personalized therapy and diagnostics: a microfluidic approach", 4th International Conference on Multifunctional, Hybrid and Nanomaterials (Hybrid Materials 2015), 9-13 March 2015, Sitges, Spain (selected oral presentation).
76. H.A. Santos*, "Nanoparticles for drug targeting", 3iRegeneration Tekes Project Workshop, 26-27th February 2015, Sannäsin Kartano, Porvoo, Finland (invited lecture).
75. H.A. Santos*, "Strategic planning with your own research group: case “Pharmaceutical Nanotechnology and Nanoporous Silicon Group", Leadership Program for Academic Staff – Competence Management, 25th November 2014, Faculty of Pharmacy, University of Helsinki, Finland (invited lecture).
74. H.A. Santos*, "On-chip production of nanocomposites for drug delivery applications using microfluidics", Turku University Centre for Materials and Surfaces, 8th Annual MATSURF Seminar, 10th November 2014, Turku, Finland (invited lecture).
73. H.A. Santos*, "Smart hybrid porous silicon-based multicomposites for controlled drug delivery and combination therapy", Laboratory of Physical Chemistry, Åbo Akademi University, 2nd October 2014, Turku, Finland (invited lecture).
72. H.A. Santos*, "Smart and multitasking nanomedicines for personalized therapy", Biomedicum Helsinki, University of Helsinki, 15th September 2014, Helsinki, Finland (invited lecture).
71. H.A. Santos*, "One small particle, one giant leap forward in disease treatment and diagnosis", Viikki Biocenter Monday Lectures Autumn 2014, University of Helsinki, 8th September 2014, Helsinki, Finland (invited lecture).
70. H.A. Santos*, "Microfluidic assisted one-step fabrication of porous silicon/acetalated dextran nanocomposites for precisely controlled combination chemotherapy", 2nd Annual Conference on International Translational Nanomedicine (ITNano), 15-27th July 2014, Boston, USA (keynote speaker).
69. H.A. Santos*, "Advanced porous silicon-based composites for precisely controlled multi-drug delivery and targeting applications", Institute for Microelectronics and Microsystems - Unit of Naples, National Research Council, 16th June 2014, Naples, Italy (invited lecture).
68. H.A. Santos*, "Nanoporous biomaterials for pharmaceutical applications", Orion Pharma, 30th April 2014, Espoo, Finland (invited lecture).
67. H.A. Santos*, "3iNano: Targeting of drugs to heart and brain", Lammi 2014, Faculty of Pharmacy - Science Fair, 23rd April 2014, Lammi, Finland (invited lecture).
66. H.A. Santos*, "Novel nanocomposites for biomedical applications: From bench to bedside", Biocentrum Helsinki – day, 14th April 2014, Helsinki Congress Paasitorni, Helsinki, Finland (invited lecture).
65. H.A. Santos*, "CHEM-Alumni career development: From university Doctoral student to full professional scientist", Career Support– event at Aalto CHEM, Learning Hub Living Room, 24th March 2014, Department of Materials Sciences (Vuorimiehentie 2), Aalto University, Finland (invited lecture).
64. H.A. Santos*, "Novel Porous Silicon Nanocomposites for Cancer Therapy", PSST-2014, Porous Semiconductors - Science and Technology Conference, 9-14th March 2014, Benidorm, Spain (selected oral presentation).
63. Hélder Santos*, "Mesoporous silicon materials for controlled drug delivery and biomedical applications", Chemistry Seminar Series, Department of Chemistry, School of Chemistry Technology, Aalto University, 14th February 2014, Espoo, Finland (invited lecture).
62. Jenni Pessi*, Inna Miroshnyk, Hélder Santos, Jouko Yliruusi, David A. Weitz, Sabirubbin Mirza, "Microfluidic approach for preparing protein loaded polycaprolactone microspheres", The Third Annual FPTP Network Meeting - Biomedicinskt centrum BMC, 29th-31st January 2014, Uppsala, Sweden (short oral presentation).
61. Chang-Fang Wang*, Ermei M. Mäkilä, Martti H. Kaasalainen, Jarno J. Salonen, Jouni T. Hirvonen, Hélder A. Santos, "Methotrexate conjugated to PSi for sustain drug release and enhanced cell uptake", The Third Annual FPTP Network Meeting - Biomedicinskt centrum BMC, 29th-31st January 2014, Uppsala, Sweden (short oral presentation).
60. H.A. Santos*, "ERC StG: Multistage-multifunctional porous silicon nanovectors for directed theranostics", The Third Annual FPTP Network Meeting - Biomedicinskt centrum BMC, 29th-31st January 2014, Uppsala, Sweden (invited speaker).
59. H. A. Santos*, "Porous silicon nanomaterials to revolutionize drug targeting and delivery", Controlled Release Society Italian Local Chapter, 21st-23rd November 2013, University of Pavia, Italy (invited speaker).
58. H. A. Santos*, "Mesoporous biomaterials in drug delivery", Controlled Release Drug Delivery Systems course (course no. 59072, 3 ECTS, 18 h), 25th September 2013, Faculty of Pharmacy, University of Helsinki, Finland (invited lecture).
57. H. A. Santos*, "Porous silicon as an emerging healthcare technology: How far are we?", Pharmaceutical Research Seminars, 11th September 2013, Faculty of Pharmacy, University of Helsinki, Finland (Young Researcher’s Award Lecture).
56. H. A. Santos*, "Tumor-homing peptide boosts porous silicon nanovectors accumulation in vivo", The European CLINAM & ETPN Summit, 23-26 June 2013, Basel, Switzerland (selected oral presentation).
55. H. A. Santos*, "Nanotechnology for healthcare", Visit of H.E. Mrs. Fátima Perestrello, the Portuguese Ambassador in Finland, to the Faculty of Pharmacy, University of Helsinki, 13th June 2013, Helsinki, Finland (invited lecture).
54. H. A. Santos*, "Biodegradable and biocompatible nanostructured porous silicon materials for biomedical applications", The Andalusian Centre for Nanomedicine and Biotechnology, BIONAND, 7 June 2013, Malaga, Spain (invited lecture).
53. H. A. Santos*, "Multifunctional nanovectors for personalized medicine", International Iberian Nanotechnology Laboratory - INL, 23 May 2013, Braga, Portugal (invited lecture).
52. H. A. Santos*, "Porous silicon nanoparticles for cancer therapy", Nanoforum (course #590297, 2 ECTS), 20-21 May 2013, University of Helsinki, Helsinki, Finland (invited lecture).
51. H. A. Santos*, "Porous silicon nanomaterials for drug delivery applications: from concept to clinic", Department of Pharmacology and Toxicology, University of Oulu, 15th May 2013, Oulu, Finland (invited lecture).
50. H. A. Santos*, "Peptide-modified porous silicon nanoparticles for tumor targeting", Division of Pharmaceutical Technology, Faculty of Pharmacy, University of Helsinki, 30th April 2013, Helsinki, Finland (invited lecture).
49. H. A. Santos*, "Nanomaterials for drug delivery and personalized medicine", Department of Biology, Facuty of Medicine, University of Azores, 10th April 2013, Ponta Delgada-Azores, Portugal (invited lecture).
48. H. A. Santos*, "Nanovectors for biomedical imaging and personalized therapy", Viikki Biocenter Monday Lectures Spring 2013, University of Helsinki, 25th March 2013, Helsinki, Finland (invited lecture).
47. H. A. Santos*, "Nanostructured porous silicon for pharmaceutical applications: safety, controlled drug delivery and imaging", Kemian Päivät ja ChemBio Finland (Finnish Chimistry and ChemBio days), 21st March 2013, Helsinki, Finland (invited lecture).
46. H. A. Santos*, "Advances in nanoporous silicon technology for pharmaceutical applications: from concept to brain tumour targeting", Division of Pharmacology and Toxicology, Faculty of Pharmacy, University of Helsinki, 8th March 2013, Helsiniki, Finland (invited lecture).
45. H. A. Santos*, "Nanostructured porous silicon-lipid composites for biomedical applications", AAPS-University of Porto Student Chapter conference: Abel Salazar Biomedical Sciences Institute/Faculty of Pharmacy, University of Porto, 17th December 2012, Porto, Portugal (invited lecture).
44. H. A. Santos*, "Nanoporous silicon as drug delivery system for cancer therapy", Faculty of Medicine, Norwegian University of Science and Technology, 19th November 2012, Trondheim, Norway (invited lecture).
43. H. A. Santos*, "Pharmaceutical applications of nanostructured porous silicon: Where do we stand and where do we go?", Department of Drug Sciences, Faculty of Pharmacy, University of Pavia, 25th October 2012, Pavia, Italy (invited lecture).
42. H. A. Santos*, "Nanostructured porous silicon for translational medicine", Molecular Cancer Biology Program, Faculty of Medicine, Biomedicum, University of Helsinki, 10th October 2012, Helsinki, Finland (invited lecture).
41. H. A. Santos*, "Porous silicon and silica biomaterials for drug delivery", Controlled Release Drug Delivery Systems course (course no. 59072, 3 ECTS, 18 h), 1st October 2012, Faculty of Pharmacy, University of Helsinki, Finland (invited lecture).
40. H.A. Santos*, L.M. Bimbo, J. Salonen, A.J. Airaksinen, M.B. Linder, J. Hirvonen, "Nanostructured porous silicon nanoparticles for drug delivery and diagnostic applications", The 9th Central European Symposium on Pharmaceutical Technology, 20-22 September 2012, Dubrovnik, Croatia (selected oral presentation).
39. L. Bimbo*, M. Sarparanta, E. Mäkilä, T. Laaksonen, P. Laaksonen, J. Salonen, M. Linder, J. Hirvonen, A. Airaksinen, H. Santos, "Surface modified nanoporous silicon particles for improved cell viability", The 9th Central European Symposium on Pharmaceutical Technology, 20-2 September 2012, Dubrovnik, Croatia (selected oral presentation).
38. H. A. Santos*, "Porous silicon nanovectors for directed theranostics", Faculty of Pharmacy, University of Helsinki, 14th September 2012, Helsinki, Finland (invited lecture).
37. H. A. Santos*, "Nanoengineered silicon-based materials for drug delivery applications", Department of Polymer Engineering, University of Minho, 26th July 2012, Braga, Portugal (invited keynote lecture).
36. H. A. Santos*, "Multifunctional porous silicon nanocarriers in preclinical development: Moving from bench to bedside", Institute of Biomedical Engineering, University of Porto, 25th July 2012, Porto, Portugal (invited lecture).
35. H. A. Santos*, "Nanostructured porous silicon platform for advanced biomedical applications", Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 24th July 2012, Porto, Portugal (invited lecture).
34. H. A. Santos*, "Biomedical applications of porous silicon: drug delivery, safety and therapy", Nanoforum (course #590297, 2 ECTS), 24-25 May 2012, University of Helsinki, Helsinki, Finland (invited lecture).
33. H. A. Santos*, European Research Council (ERC) Starting Grant Interview, Life Sciences Panel (LS7), 8th of May 2012, Covent Garden-Place Rogier, Brussels, Belgium (invited interview).
32. H. A. Santos*, "Nanocarriers for advanced drug delivery applications: porous silicon materials", School of Engineering and Applied Sciences/Department of Physics, Harvard University, 10th April 2012, Cambridge, USA (invited lecture).
31. H. A. Santos*, L. M. Bimbo, M. Sarparanta, E. Mäkilä, J. Salonen, T. Laaksonen, M. B. Linder, A.J. Airaksinen, J. Hirvonen, "Hydrophobin-coated nanoporous silicon for controlled drug delivery and therapy applications", 8th International Conference, Porous Semiconductors - Science and Technology (PSST-2012), 25-30 March 2012, Malaga, Spain (selected oral presentation).
30. Participation in the panel discussion: How to bridge the gap between engineers, clinical scientists and doctors, 3rd International Congress BioNanoMed 2012 - Nanotechnology enables Personalised Medicine, 1-2 March 2012, Krems, Austria (selected oral presentation).
29. H. A. Santos*, L. M. Bimbo, M. Sarparanta, E. Mäkilä, J. Salonen, M. B. Linder, A.J. Airaksinen, J. Hirvonen, "Biocompatibility of nanoporous silicon materials for controlled drug release, diagnostics and therapy", 3rd International Congress BioNanoMed 2012 - Nanotechnology enables Personalised Medicine, 1-2 March 2012, Krems, Austria (selected oral presentation).
28. H. A. Santos*, "Nanoparticles in drug delivery", Tfy-125.4003 (5 ECTS) Nanoscience III: Molecular Nanoscience course (2 h), 15th February 2012, Aalto University, Espoo, Finland (invited lecture).
27. H. A. Santos*, "Nanotechnology research at the Viikki campus of the University of Helsinki: from the bench to the bedside", Visit of H.E. Mr. Anibal Cavaco Silva, the President of the Portuguese Republic to Aalto University, 9th February 2012, Espoo, Finland (invited oral presentation).
26. H. A. Santos*/L. M. Bimbo, "Nanoporous silicon materials for enhanced drug release", NORDFORSK - Future performance testing of pharmaceuticals seminar, 7th February 2012, University of Helsinki, Helsinki, Finland (invited lecture).
25. H. A. Santos*, "Porous silicon for improving drug release and drug bioavailability", Laboratory of Radiochemistry, Faculty of Sciences, 2nd November 2011, University of Helsinki, Finland (invited lecture).
24. H. A. Santos*, "Nanoporous materials for controlled drug delivery", Controlled Release Drug Delivery Systems course (course no. 59072, 3 ECTS, 18 h), 5th October 2011, Faculty of Pharmacy, University of Helsinki, Finland (invited lecture).
23. L.M. Bimbo*, E. Mäkilä, M. Sarparanta, T. Laaksonen, L. Peltonen, V.-P. Lehto, J. Salonen, A.J. Airaksinen, J. Hirvonen, H. A. Santos, "Mesoporous silicon particles as biocompatible drug delivery agents for enhancement of drug permeation", 5th PSSRC Symposium, 26-27 September 2011, Helsinki, Finland (Abstract + Poster + Short oral presentation).
22. M. Sarparanta, L.M. Bimbo, E. Mäkilä, J. Salonen, H.A. Santos, T. Laaksonen, J. Hirvonen, V.-P. Lehto, P. Laaksonen, M.B. Linder, A.J. Airaksinen*, "18F-Radiolabeling as a tool in the evaluation of porous silicon particles for drug delivery", XX Helsinki Drug Research Congress, 19-21 September 2011, Helsinki, Finland (Abstract + Oral presentation).
21. H. A. Santos*, "Nanoporous materials for non-invasive imaging and improving drug bioavailability", Biopharmaceutics in Pharmaceutical Product Development 2011 course (590278 Biofarmasia farmaseuttisessa tuotekehityksessä), 1st September 2011, University of Helsinki, Helsinki, Finland (invited lecture).
20. H. A. Santos*, "Nanoporous silicon materials for improved drug bioavailability", Public trial lecture for docentship (Adjunct Professor) in Pharmaceutical Nanotechnology, 25th August 2011, University of Helsinki, Helsinki, Finland.
19. L. M. Bimbo*, E. Mäkilä, M. Sarparanta, T. Laaksonen, A. Airaksinen, V.-P. Lehto, J. Salonen, J. Hirvonen, H. A. Santos, "Mesoporous silicon particles as emerging nanomedicine carriers", 3rd European Summer School in Nanomedicine, 14-19 June 2011, Wittenberg, Germany (selected oral presentation).
18. L. M. Bimbo*, E. Mäkilä, M. Sarparanta, T. Laaksonen, V.-P. Lehto, A. Airaksinen, J. Salonen, J. Hirvonen, H. A. Santos, "Biocompatibile functionalization of silicon nanoparticles", 3rd PharmScifair, 13-17 June 2011, Prague, Czech Republic (invited speaker).
17. L.M. Bimbo, M. Sarparanta, E. Mäkilä, T. Laaksonen, V.-P. Lehto, L. Peltonen, A.J. Airaksinen, J. Salonen, J. Hirvonen, H. A. Santos*, "Multifunctional porous silicon for therapeutic drug delivery and imaging", 3rd PharmScifair, 13-17 June 2011, Prague, Czech Republic (selected presentation).
16. H. A. Santos*, "Current research in mesoporous materials", Biocentrum Helsinki Networking Event – "Connecting Aalto University and University of Helsinki Scientists", 1st June 2011, Dipoli, Espoo-Helsinki, Finland (short presentation).
15. H. A. Santos*, "Nanoporous silicon materials as a nanomedicine platform: from drug delivery and imaging to cancer therapy", The Institute for Molecular Medicine Finland (FIMM), University of Helsinki, 20th April 2011, Helsinki, Finland (invited lecture).
14. H. A. Santos*, "Multifunctional porous silicon as a nanomedicine platform for therapeutic drug delivery and imaging", Department of Pharmacy, Faculty of Medicine, University of Tartu, 14th April 2011, Tartu, Estonia (invited lecture).
13. H. A. Santos*, "Nanoporous silicon as a nanomedicine platform for imaging and delivery of therapeutics", Tumor Progression and Metastasis Lab, Faculty of Medicine, Biomedicum, University of Helsinki, 28th March 2011, Helsinki, Finland (invited lecture).
12. L. M. Bimbo, M. Sarparanta, J. Salonen, J. Riikonen, E. Mäkilä, A. Airaksinen, V.-P. Lehto, J. Hirvonen, H. A. Santos*, "Nanoporous silicon materials in drug delivery applications", 23rd European Conference on Biomaterials (ESB2010), 11–15 September 2010, Tampere, Finland (selected keynote).
11. M Sarparanta*, E Mäkilä, T Heikkilä, J Salonen , V-P Lehto, H A Santos, J Hirvonen, AJ Airaksinen, "Biodistribution of 18F-labeled thermally hydrocarbonized porous silicon nanoparticles", 7th International Conference Porous Semicondictures Science & Technology (PSST-2010), 14–19th March 2010, Valencia, Spain (selected presentation).
10. T Rotko*, E Mäkilä, H Santos, T Laaksonen, J Salonen, J Hirvonen, L Peltonen, "Tablet formulations of drug-loaded mesoporous silicon particles: enhanced dissolution for poorly soluble drugs", 7th World Meeting on Pharmaceutics, Biopharmaceutics, and Pharmaceutical Technology, 8–11th March 2010, Valletta, Malta (selected presentation).
9. Hélder A. Santos*, Luis M. Bimbo, Jarno Salonen, Joakim Riikonen, Ermei Mäkilä, Timo Laaksonen, Leena Peltonen, Vesa-Pekka Lehto, Jouni Hirvonen, "Towards enhanced bioavailability and feasibility of nanoporous silicon materials as an alternative for oral drug delivery", 7th World Meeting on Pharmaceutics, Biopharmaceutics, and Pharmaceutical Technology, 8–11th March 2010, Valletta, Malta (selected presentation).
8. H. A. Santos*, "Mesoporous materials for therapeutic applications: from in vitro to animal tests", Pharmaceutical Research Seminars, Division of Pharmaceutical Technology, Faculty of Pharmacy, 3rd February 2010, University of Helsinki, Finland (lecture).
7. H. A. Santos*, "PSi Micro- & Nanoparticles Regarding Drug Release, Drug Permeability, Cytotoxicity And Cellular Association", 1st National MedPSi Days, 1-2.10.2009, University of Helsinki, Finland (invited lecture).
6. T. Heikkilä*, E. Mäkilä, S. Ojanen, H. Qu, M. Louhi-Kultanen, J. Riikonen, J. Salonen, N. Kumar, D. Yu. Murzin, H. A. Santos, T. Laaksonen, L. Peltonen, J. Hirvonen, V-P. Lehto, "Effect of comminution on microparticle properties of mesoporous silicon and silica materials", European Symposium on Comminution and Classification (ESCC09), 15–18th September 2009, Helsinki University of Technology, Espoo/Otaniemi, Finland (selected presentation).
5. Hélder A. Santos*, Joakim Riikonen, Teemu Heikkilä, Jarno Salonen, Luis Bimbo, Timo Laaksonen, Leena Peltonen, Vesa-Pekka Lehto, Jouni Hirvonen, "Evaluation of the cytotoxicity of meso/nanoporous silicon based materials", 2nd Pharmaceutical Sciences Fair & Exhibition (PharmSciFair), 7–12 June 2009, Nice, France (selected presentation).
4. H. A. Santos*, "Nanoporous Silicon: a platform for delivery of therapeutics", Pharmaceutical Research Seminars, Division of Pharmaceutical Technology, Faculty of Pharmacy, 22nd April 2009, University of Helsinki, Finland (lecture).
3. H. A. Santos*, "Nanoporous silicon/silica: an alternative for drug delivery", IX Seminar of the Faculty of Pharmacy and Centre of Drug Research (CDR), Lammi Biological Station, 16–17th April 2009, University of Helsinki, Finland (invited lecture).
2. H. A. Santos*, T. Heikkilä, J. Riikonen, T. Lautenschlager, T. Laaksonen, L. Peltonen, J. Salonen, N. Kumar, D. Yu. Murzin, V.-P. Lehto, J. Hirvonen, "Investigating Cell Toxicity and Drug Dissolution Profiles Using Mesoporous Silica and Silicon Based Materials", 6th World Meeting on Pharmaceutics, Biopharmaceutics, and Pharmaceutical Technology, 7–10th April 2008, Barcelona, Spain (selected presentation).
1. J. Salonen*, E. Mäkilä, J. Riikonen, T. Heikkilä, H. Santos, A.-M. Kaukonen, L. Peltonen, T. Laaksonen, J. Hirvonen, M. Kilpeläinen, M. Vlasova, K.-H. Herzig, J. Mönkäre, K. Järvinen, V.-P. Lehto, "Surface Chemistry Effects in Drug Delivery Applications of Porous Silicon", Porous Semicondictures Science & Technology (PSST-2008), 10–14th March 2008, Mallorca, Spain (selected presentation).